| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA333142
Max Phase: Preclinical
Molecular Formula: C10H13N5S
Molecular Weight: 235.32
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=CCN/C(S)=N/N=C(\C)c1cnccn1
Standard InChI: InChI=1S/C10H13N5S/c1-3-4-13-10(16)15-14-8(2)9-7-11-5-6-12-9/h3,5-7H,1,4H2,2H3,(H2,13,15,16)/b14-8+
Standard InChI Key: VUZFTZDWWYQJOE-RIYZIHGNSA-N
Associated Targets(Human)
HuT78 515 Activities
MT4 17854 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 235.32 | Molecular Weight (Monoisotopic): 235.0892 | AlogP: 1.26 | #Rotatable Bonds: 4 |
| Polar Surface Area: 62.53 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 6.63 | CX Basic pKa: 2.99 | CX LogP: 0.57 | CX LogD: -0.11 |
| Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.27 | Np Likeness Score: -1.40 |
References
| 1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |
Source
Source(1):